$9.50
+0.17 (+1.82%)
Performance
1D
—
1W
—
1M
—
3M
+40.64%
6M
-50.00%
1Y
-50.00%
YTD
-50.00%
Open$9.17
Previous Close$9.33
Day High$9.67
Day Low$8.66
52W High$24.37
52W Low$5.50
Volume—
Avg Volume113.7K
Market Cap5.54B
P/E Ratio—
EPS$-0.61
SectorN/A
Technical Indicators
Full analysis →
RSI (14)
72.7
Overbought
Analyst Ratings
Strong Buy
7 analysts
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 897.79M | 924.30M | 800.01M |
| Net Income | 130.26M | 123.87M | 128.43M |
| Profit Margin | 14.5% | 13.4% | 16.1% |
| EBITDA | 262.26M | 279.12M | 215.46M |
| Free Cash Flow | 117.43M | 106.34M | 120.15M |
| Rev Growth | +21.7% | -6.1% | -8.9% |
| Debt/Equity | 0.23 | 0.23 | 0.24 |
N/A Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| PICS | Pics Nv | $11.88 | +1.97% | — | 1.64B |
| DMII | Drugs Made In America Acquis | $10.01 | -0.05% | 152.4 | 637.96M |
| CCCX | Churchill Capital Corp X-A | $10.08 | -5.62% | — | 2.87B |
| BEAG | Bold Eagle Acquisition Cor-A | $10.55 | +0.09% | 62.0 | 605.71M |
| CEPF | Cantor Equity Partners-Cl A | $10.28 | +0.24% | 96.1 | 589.22M |
| BCSS | Bain Capital Gss Inv- A | $10.15 | +0.20% | — | 593.34M |